|

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

RECRUITINGEarly 1Sponsored by University of Pennsylvania
Actively Recruiting
PhaseEarly 1
SponsorUniversity of Pennsylvania
Started2022-09-01
Est. completion2027-07-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05377216

Summary

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Planned catheter based VT ablation
* Age at least 18 years

Exclusion Criteria:

* Pregnancy
* Contraindication to SGB or VT ablation
* Hypersensitivity of local anesthetic of amide type
* Hemodynamic instability during the procedure prior to the study protocol

Conditions2

Heart DiseaseVentricular Tachycardia

Locations1 site

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Timothy Markman, MD

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.